Guilford, CT, United States of America

Timothy M Caldwell

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 7.2

ph-index = 4

Forward Citations = 56(Granted Patents)


Location History:

  • Branford, CT (US) (2005 - 2006)
  • Guilford, CT (US) (2007 - 2011)

Company Filing History:


Years Active: 2005-2011

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Timothy M Caldwell

Introduction

Timothy M Caldwell is a notable inventor based in Guilford, CT (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, Caldwell has made strides in developing compounds that have the potential to treat various medical conditions.

Latest Patents

Caldwell's latest patents include "Substituted biaryl quinolin-4-ylamine analogues," which are designed to modulate specific receptor activity both in vivo and in vitro. These compounds are particularly useful in treating conditions associated with pathological receptor activation in humans, domesticated companion animals, and livestock animals. Additionally, he has developed "Dipiperazinyl ketones and related analogues," which can modulate ligand binding to histamine H3 receptors. These compounds also hold promise for treating a variety of disorders in both humans and animals.

Career Highlights

Caldwell is currently associated with Neurogen Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on creating effective therapeutic methods and pharmaceutical compositions that can improve health outcomes.

Collaborations

Caldwell has collaborated with notable colleagues such as Rajagopal Bakthavatchalam and Kevin J Hodgetts, enhancing the research and development efforts at Neurogen Corporation.

Conclusion

Timothy M Caldwell's work exemplifies the impact of innovative thinking in the pharmaceutical field. His patents and ongoing research contribute significantly to advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…